BE726681A - - Google Patents

Info

Publication number
BE726681A
BE726681A BE726681DA BE726681A BE 726681 A BE726681 A BE 726681A BE 726681D A BE726681D A BE 726681DA BE 726681 A BE726681 A BE 726681A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE726681A publication Critical patent/BE726681A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
BE726681D 1968-01-10 1969-01-09 BE726681A (US06312121-20011106-C00033.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0536/68A GB1202607A (en) 1968-01-10 1968-01-10 Improvements in or relating to stable glucagon solutions and their preparation

Publications (1)

Publication Number Publication Date
BE726681A true BE726681A (US06312121-20011106-C00033.png) 1969-07-09

Family

ID=9723689

Family Applications (1)

Application Number Title Priority Date Filing Date
BE726681D BE726681A (US06312121-20011106-C00033.png) 1968-01-10 1969-01-09

Country Status (7)

Country Link
AT (1) AT283600B (US06312121-20011106-C00033.png)
BE (1) BE726681A (US06312121-20011106-C00033.png)
DE (1) DE1900367A1 (US06312121-20011106-C00033.png)
FR (1) FR2000114A1 (US06312121-20011106-C00033.png)
GB (1) GB1202607A (US06312121-20011106-C00033.png)
IT (1) IT974528B (US06312121-20011106-C00033.png)
NL (1) NL6900460A (US06312121-20011106-C00033.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
ATE269103T1 (de) * 1998-03-13 2004-07-15 Novo Nordisk As Stabilisierte wässerige glukagonlösungen enthaltend detergenzien
WO1999047160A1 (en) * 1998-03-13 1999-09-23 Novo Nordisk A/S Stabilized aqueous peptide solutions
US9610329B2 (en) 2009-10-22 2017-04-04 Albireo Pharma, Inc. Stabilized glucagon solutions
WO2011049713A2 (en) 2009-10-22 2011-04-28 Biodel Inc. Stabilized glucagon solutions
WO2012059764A1 (en) 2010-11-03 2012-05-10 Arecor Limited Novel composition comprising glucagon
CN104114155B (zh) 2012-01-09 2019-02-15 阿道恰公司 Ph为7并且至少包含pi为5.8至8.5之基础胰岛素和经取代共聚(氨基酸)的可注射溶液
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
FR3061660B1 (fr) * 2017-01-10 2019-05-31 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3052071B1 (fr) * 2016-06-07 2018-09-07 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
MX2018015069A (es) * 2016-06-07 2019-05-09 Adocia Composiciones bajo la forma de solución acuosa inyectable que comprende glucagón humano y co-poliaminoacido estadístico.
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
FR3074683B1 (fr) * 2017-12-07 2020-01-10 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
WO2019110836A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
JP2021505597A (ja) 2017-12-07 2021-02-18 アドシア ヒトグルカゴンおよびコポリアミノ酸を含む注射水溶液の形態の組成物
FR3083087A1 (fr) 2018-06-29 2020-01-03 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
US20190275110A1 (en) 2017-12-07 2019-09-12 Adocia Compositions in the form of an injectale aqueous solution comprising human glucagon and a co-polyamino acid
MX2020005915A (es) 2017-12-07 2020-10-19 Adocia Composiciones en forma de una solución acuosa inyectable que comprende glucagón humano y un copoliaminoácido.
FR3067247A1 (fr) 2018-06-07 2018-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Also Published As

Publication number Publication date
IT974528B (it) 1974-07-10
FR2000114A1 (fr) 1969-08-29
AT283600B (de) 1970-08-10
NL6900460A (US06312121-20011106-C00033.png) 1969-07-14
GB1202607A (en) 1970-08-19
DE1900367A1 (de) 1969-09-04

Similar Documents

Publication Publication Date Title
AU1946070A (US06312121-20011106-C00033.png)
AU428130B2 (US06312121-20011106-C00033.png)
AU2374870A (US06312121-20011106-C00033.png)
AU5184069A (US06312121-20011106-C00033.png)
AU6168869A (US06312121-20011106-C00033.png)
AU6171569A (US06312121-20011106-C00033.png)
AU429879B2 (US06312121-20011106-C00033.png)
AU416157B2 (US06312121-20011106-C00033.png)
AU2581067A (US06312121-20011106-C00033.png)
AU4811568A (US06312121-20011106-C00033.png)
AU421558B1 (US06312121-20011106-C00033.png)
AU3224368A (US06312121-20011106-C00033.png)
AU3789668A (US06312121-20011106-C00033.png)
AU2580267A (US06312121-20011106-C00033.png)
AU4744468A (US06312121-20011106-C00033.png)
AR203075Q (US06312121-20011106-C00033.png)
BE720778A (US06312121-20011106-C00033.png)
AU3083868A (US06312121-20011106-C00033.png)
AU4558658A (US06312121-20011106-C00033.png)
AU463027A (US06312121-20011106-C00033.png)
AU2496167A (US06312121-20011106-C00033.png)
BE712933A (US06312121-20011106-C00033.png)
BE712699A (US06312121-20011106-C00033.png)
BE711789A (US06312121-20011106-C00033.png)
BE709496A (US06312121-20011106-C00033.png)